Daratumumab for antibody-mediated rejection: Is it time to target the real culprit?
Insights into novel therapies for managing antibody-mediated rejection can enhance transplant outcomes.
More from ASNRT News
Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.
All news · ASNRT home